Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamzeh Karimkhanloo

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 6, 2017
Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinomaHamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Zeinab Ahsani, et al.
Molecular Biology Reports|September 9, 2020
Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinomaHamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Razie Hadavi, et al.
Applied Biochemistry and Biotechnology|October 1, 2016
WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular CarcinomaZeinab Ahsani, Samira Mohammadi-Yeganeh, Vahid Kia, et al.
Nanoscale Research Letters|August 30, 2014
Carbon nanotubes: properties, synthesis, purification, and medical applicationsAli Eatemadi, Hadis Daraee, Hamzeh Karimkhanloo, et al.
The Journal of Endocrinology|December 8, 2020
Circulating cathepsin S improves glycaemic control in miceHamzeh Karimkhanloo, Stacey N Keenan, Emily W Sun, et al.
Proteomes|June 2, 2021
Western Diet Induced Remodelling of the Tongue ProteomeMriga Dutt, Yaan-Kit Ng, Jeffrey Molendijk, et al.
Scientific Reports|March 23, 2023
Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studiesHamzeh Karimkhanloo, Stacey N Keenan, Jacqueline Bayliss, et al.
Cell Reports|December 12, 2024
Lipidome profiling in advanced metabolic liver disease identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolismMarziyeh Anari, Hamzeh Karimkhanloo, Shuai Nie, et al.
Nature Communications|March 11, 2022
Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic controlMagdalene K Montgomery, Jacqueline Bayliss, Shuai Nie, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 6, 2017
Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinomaHamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Zeinab Ahsani, et al.
Molecular Biology Reports|September 9, 2020
Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinomaHamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Razie Hadavi, et al.
Applied Biochemistry and Biotechnology|October 1, 2016
WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular CarcinomaZeinab Ahsani, Samira Mohammadi-Yeganeh, Vahid Kia, et al.
Nanoscale Research Letters|August 30, 2014
Carbon nanotubes: properties, synthesis, purification, and medical applicationsAli Eatemadi, Hadis Daraee, Hamzeh Karimkhanloo, et al.
The Journal of Endocrinology|December 8, 2020
Circulating cathepsin S improves glycaemic control in miceHamzeh Karimkhanloo, Stacey N Keenan, Emily W Sun, et al.
Proteomes|June 2, 2021
Western Diet Induced Remodelling of the Tongue ProteomeMriga Dutt, Yaan-Kit Ng, Jeffrey Molendijk, et al.
Scientific Reports|March 23, 2023
Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studiesHamzeh Karimkhanloo, Stacey N Keenan, Jacqueline Bayliss, et al.
Cell Reports|December 12, 2024
Lipidome profiling in advanced metabolic liver disease identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolismMarziyeh Anari, Hamzeh Karimkhanloo, Shuai Nie, et al.
Nature Communications|March 11, 2022
Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic controlMagdalene K Montgomery, Jacqueline Bayliss, Shuai Nie, et al.
Pageof 1